nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—CA3—respiratory system—chronic obstructive pulmonary disease	0.00597	0.133	CbGeAlD
Lacosamide—CA3—connective tissue—chronic obstructive pulmonary disease	0.00526	0.117	CbGeAlD
Lacosamide—Bortezomib—CYP1A1—chronic obstructive pulmonary disease	0.00452	0.223	CrCbGaD
Lacosamide—Bortezomib—CYP1A2—chronic obstructive pulmonary disease	0.00436	0.215	CrCbGaD
Lacosamide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00335	0.0748	CbGeAlD
Lacosamide—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00341	CcSEcCtD
Lacosamide—CA3—lung—chronic obstructive pulmonary disease	0.00317	0.0708	CbGeAlD
Lacosamide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00315	0.00337	CcSEcCtD
Lacosamide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00315	0.00337	CcSEcCtD
Lacosamide—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00315	0.00337	CcSEcCtD
Lacosamide—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00314	0.00336	CcSEcCtD
Lacosamide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00314	0.00336	CcSEcCtD
Lacosamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00314	0.00336	CcSEcCtD
Lacosamide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00312	0.00333	CcSEcCtD
Lacosamide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00312	0.00333	CcSEcCtD
Lacosamide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00311	0.00332	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00309	0.00331	CcSEcCtD
Lacosamide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00308	0.0033	CcSEcCtD
Lacosamide—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00306	0.00328	CcSEcCtD
Lacosamide—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00306	0.00328	CcSEcCtD
Lacosamide—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00305	0.00326	CcSEcCtD
Lacosamide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00305	0.00326	CcSEcCtD
Lacosamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00302	0.00323	CcSEcCtD
Lacosamide—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.003	0.00321	CcSEcCtD
Lacosamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00299	0.0032	CcSEcCtD
Lacosamide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00299	0.0032	CcSEcCtD
Lacosamide—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.00319	CcSEcCtD
Lacosamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00298	0.00318	CcSEcCtD
Lacosamide—Phentermine—SLC6A4—chronic obstructive pulmonary disease	0.00297	0.147	CrCbGaD
Lacosamide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00297	0.00318	CcSEcCtD
Lacosamide—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00297	0.00318	CcSEcCtD
Lacosamide—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00297	0.00318	CcSEcCtD
Lacosamide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00294	0.00314	CcSEcCtD
Lacosamide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00293	0.00313	CcSEcCtD
Lacosamide—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00291	0.00311	CcSEcCtD
Lacosamide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.0029	0.0031	CcSEcCtD
Lacosamide—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00289	0.0031	CcSEcCtD
Lacosamide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00306	CcSEcCtD
Lacosamide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00304	CcSEcCtD
Lacosamide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00304	CcSEcCtD
Lacosamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00282	0.00302	CcSEcCtD
Lacosamide—SCN9A—lung—chronic obstructive pulmonary disease	0.00282	0.063	CbGeAlD
Lacosamide—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00281	0.003	CcSEcCtD
Lacosamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00279	0.00298	CcSEcCtD
Lacosamide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00278	0.00297	CcSEcCtD
Lacosamide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00277	0.00296	CcSEcCtD
Lacosamide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00277	0.00296	CcSEcCtD
Lacosamide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00275	0.00294	CcSEcCtD
Lacosamide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00271	0.0029	CcSEcCtD
Lacosamide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00271	0.0029	CcSEcCtD
Lacosamide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00271	0.0029	CcSEcCtD
Lacosamide—Phentermine—CYP1A2—chronic obstructive pulmonary disease	0.00271	0.134	CrCbGaD
Lacosamide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.00289	CcSEcCtD
Lacosamide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00289	CcSEcCtD
Lacosamide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00289	CcSEcCtD
Lacosamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00268	0.00287	CcSEcCtD
Lacosamide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00287	CcSEcCtD
Lacosamide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00266	0.00284	CcSEcCtD
Lacosamide—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00266	0.00284	CcSEcCtD
Lacosamide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00264	0.00283	CcSEcCtD
Lacosamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00263	0.00281	CcSEcCtD
Lacosamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00262	0.0585	CbGeAlD
Lacosamide—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00261	0.0028	CcSEcCtD
Lacosamide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00279	CcSEcCtD
Lacosamide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.00279	CcSEcCtD
Lacosamide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00261	0.00279	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00258	0.00276	CcSEcCtD
Lacosamide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00274	CcSEcCtD
Lacosamide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00256	0.00273	CcSEcCtD
Lacosamide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00255	0.00273	CcSEcCtD
Lacosamide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00273	CcSEcCtD
Lacosamide—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00252	0.00269	CcSEcCtD
Lacosamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00252	0.00269	CcSEcCtD
Lacosamide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00251	0.00269	CcSEcCtD
Lacosamide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00251	0.00269	CcSEcCtD
Lacosamide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00268	CcSEcCtD
Lacosamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00268	CcSEcCtD
Lacosamide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00268	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0025	0.00267	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0025	0.00267	CcSEcCtD
Lacosamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00266	CcSEcCtD
Lacosamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00266	CcSEcCtD
Lacosamide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00264	CcSEcCtD
Lacosamide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00246	0.00263	CcSEcCtD
Lacosamide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00246	0.00263	CcSEcCtD
Lacosamide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.00262	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00245	0.00262	CcSEcCtD
Lacosamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00254	CcSEcCtD
Lacosamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00237	0.00254	CcSEcCtD
Lacosamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00253	CcSEcCtD
Lacosamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00253	CcSEcCtD
Lacosamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00251	CcSEcCtD
Lacosamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00234	0.0025	CcSEcCtD
Lacosamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.0025	CcSEcCtD
Lacosamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.0025	CcSEcCtD
Lacosamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00232	0.00248	CcSEcCtD
Lacosamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00248	CcSEcCtD
Lacosamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00245	CcSEcCtD
Lacosamide—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.00229	0.113	CrCbGaD
Lacosamide—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00228	0.00244	CcSEcCtD
Lacosamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.0024	CcSEcCtD
Lacosamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.0024	CcSEcCtD
Lacosamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00239	CcSEcCtD
Lacosamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00236	CcSEcCtD
Lacosamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00235	CcSEcCtD
Lacosamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00235	CcSEcCtD
Lacosamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00233	CcSEcCtD
Lacosamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00233	CcSEcCtD
Lacosamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00217	0.0485	CbGeAlD
Lacosamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00217	0.00232	CcSEcCtD
Lacosamide—SCN10A—lung—chronic obstructive pulmonary disease	0.00215	0.048	CbGeAlD
Lacosamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00229	CcSEcCtD
Lacosamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00229	CcSEcCtD
Lacosamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00228	CcSEcCtD
Lacosamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00212	0.00227	CcSEcCtD
Lacosamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00212	0.00227	CcSEcCtD
Lacosamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00212	0.00227	CcSEcCtD
Lacosamide—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.00212	0.105	CrCbGaD
Lacosamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00211	0.00226	CcSEcCtD
Lacosamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00225	CcSEcCtD
Lacosamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00209	0.00224	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00223	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00223	CcSEcCtD
Lacosamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00208	0.00222	CcSEcCtD
Lacosamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00222	CcSEcCtD
Lacosamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00222	CcSEcCtD
Lacosamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00206	0.0022	CcSEcCtD
Lacosamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.0022	CcSEcCtD
Lacosamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.0022	CcSEcCtD
Lacosamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00219	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00218	CcSEcCtD
Lacosamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00218	CcSEcCtD
Lacosamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00216	CcSEcCtD
Lacosamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00201	0.00215	CcSEcCtD
Lacosamide—CA5B—lung—chronic obstructive pulmonary disease	0.00201	0.045	CbGeAlD
Lacosamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.002	0.00214	CcSEcCtD
Lacosamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.002	0.00214	CcSEcCtD
Lacosamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.002	0.00213	CcSEcCtD
Lacosamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00212	CcSEcCtD
Lacosamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00212	CcSEcCtD
Lacosamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00212	CcSEcCtD
Lacosamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00198	0.00211	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.0021	CcSEcCtD
Lacosamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.0021	CcSEcCtD
Lacosamide—SCN3A—lung—chronic obstructive pulmonary disease	0.00196	0.0437	CbGeAlD
Lacosamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00208	CcSEcCtD
Lacosamide—CA4—trachea—chronic obstructive pulmonary disease	0.00193	0.0432	CbGeAlD
Lacosamide—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00193	0.00206	CcSEcCtD
Lacosamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00192	0.00205	CcSEcCtD
Lacosamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00192	0.00205	CcSEcCtD
Lacosamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00191	0.0427	CbGeAlD
Lacosamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00204	CcSEcCtD
Lacosamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00204	CcSEcCtD
Lacosamide—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.0019	0.00203	CcSEcCtD
Lacosamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0019	0.00203	CcSEcCtD
Lacosamide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00189	0.00202	CcSEcCtD
Lacosamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00201	CcSEcCtD
Lacosamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00201	CcSEcCtD
Lacosamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00188	0.00201	CcSEcCtD
Lacosamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00188	0.00201	CcSEcCtD
Lacosamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00201	CcSEcCtD
Lacosamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.002	CcSEcCtD
Lacosamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00187	0.002	CcSEcCtD
Lacosamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00187	0.002	CcSEcCtD
Lacosamide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00184	0.00197	CcSEcCtD
Lacosamide—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00196	CcSEcCtD
Lacosamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.00193	CcSEcCtD
Lacosamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00192	CcSEcCtD
Lacosamide—CA2—bronchus—chronic obstructive pulmonary disease	0.00179	0.0399	CbGeAlD
Lacosamide—CA1—lung—chronic obstructive pulmonary disease	0.00178	0.0397	CbGeAlD
Lacosamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00178	0.0019	CcSEcCtD
Lacosamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.0019	CcSEcCtD
Lacosamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.0019	CcSEcCtD
Lacosamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00175	0.039	CbGeAlD
Lacosamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00186	CcSEcCtD
Lacosamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00185	CcSEcCtD
Lacosamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00185	CcSEcCtD
Lacosamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00182	CcSEcCtD
Lacosamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00182	CcSEcCtD
Lacosamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00181	CcSEcCtD
Lacosamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00179	CcSEcCtD
Lacosamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00179	CcSEcCtD
Lacosamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00176	CcSEcCtD
Lacosamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00176	CcSEcCtD
Lacosamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Lacosamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00173	CcSEcCtD
Lacosamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00172	CcSEcCtD
Lacosamide—CA2—trachea—chronic obstructive pulmonary disease	0.0016	0.0358	CbGeAlD
Lacosamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00171	CcSEcCtD
Lacosamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.0017	CcSEcCtD
Lacosamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00159	0.0017	CcSEcCtD
Lacosamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Lacosamide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Lacosamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Lacosamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Lacosamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Lacosamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00163	CcSEcCtD
Lacosamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00163	CcSEcCtD
Lacosamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00162	CcSEcCtD
Lacosamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00162	CcSEcCtD
Lacosamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00162	CcSEcCtD
Lacosamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00162	CcSEcCtD
Lacosamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00161	CcSEcCtD
Lacosamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00161	CcSEcCtD
Lacosamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Lacosamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00159	CcSEcCtD
Lacosamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00159	CcSEcCtD
Lacosamide—Depression—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00159	CcSEcCtD
Lacosamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00158	CcSEcCtD
Lacosamide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00156	CcSEcCtD
Lacosamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00155	CcSEcCtD
Lacosamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00154	CcSEcCtD
Lacosamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00153	CcSEcCtD
Lacosamide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Lacosamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Lacosamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Lacosamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Lacosamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Lacosamide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00141	0.0015	CcSEcCtD
Lacosamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0014	0.0015	CcSEcCtD
Lacosamide—CA4—lung—chronic obstructive pulmonary disease	0.00139	0.031	CbGeAlD
Lacosamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00145	CcSEcCtD
Lacosamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00145	CcSEcCtD
Lacosamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00135	0.00144	CcSEcCtD
Lacosamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00142	CcSEcCtD
Lacosamide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00131	0.0014	CcSEcCtD
Lacosamide—Nateglinide—ALB—chronic obstructive pulmonary disease	0.00129	0.0638	CrCbGaD
Lacosamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Lacosamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Lacosamide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00133	CcSEcCtD
Lacosamide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Lacosamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00126	CcSEcCtD
Lacosamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Lacosamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Lacosamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Lacosamide—CA2—lung—chronic obstructive pulmonary disease	0.00115	0.0257	CbGeAlD
Lacosamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00117	CcSEcCtD
Lacosamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00115	CcSEcCtD
Lacosamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00115	CcSEcCtD
Lacosamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00114	CcSEcCtD
Lacosamide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Lacosamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Lacosamide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00111	CcSEcCtD
Lacosamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00111	CcSEcCtD
Lacosamide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00109	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000983	0.00105	CcSEcCtD
Lacosamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000978	0.00105	CcSEcCtD
Lacosamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000962	0.00103	CcSEcCtD
Lacosamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000933	0.000998	CcSEcCtD
Lacosamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00093	0.000995	CcSEcCtD
Lacosamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000921	0.000986	CcSEcCtD
Lacosamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000917	0.000981	CcSEcCtD
Lacosamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000863	0.000923	CcSEcCtD
Lacosamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000858	0.000918	CcSEcCtD
Lacosamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000852	0.000911	CcSEcCtD
Lacosamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000835	0.000893	CcSEcCtD
Lacosamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000823	0.00088	CcSEcCtD
Lacosamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000822	0.00088	CcSEcCtD
Lacosamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000818	0.000875	CcSEcCtD
Lacosamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000818	0.000875	CcSEcCtD
Lacosamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000811	0.000868	CcSEcCtD
Lacosamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000782	0.000836	CcSEcCtD
Lacosamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000775	0.000829	CcSEcCtD
Lacosamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000754	0.000806	CcSEcCtD
Lacosamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00075	0.000802	CcSEcCtD
Lacosamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000699	0.000748	CcSEcCtD
Lacosamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000681	0.000728	CcSEcCtD
Lacosamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000671	0.000718	CcSEcCtD
Lacosamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000649	0.000694	CcSEcCtD
Lacosamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000627	0.000671	CcSEcCtD
Lacosamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000603	0.000645	CcSEcCtD
Lacosamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000598	0.00064	CcSEcCtD
Lacosamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000598	0.000639	CcSEcCtD
Lacosamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000594	0.000636	CcSEcCtD
Lacosamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000563	0.000603	CcSEcCtD
